These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 30506571)

  • 1. Cannabinoid-1 Receptor Antagonism Improves Glycemic Control and Increases Energy Expenditure Through Sirtuin-1/Mechanistic Target of Rapamycin Complex 2 and 5'Adenosine Monophosphate-Activated Protein Kinase Signaling.
    Liu J; Godlewski G; Jourdan T; Liu Z; Cinar R; Xiong K; Kunos G
    Hepatology; 2019 Apr; 69(4):1535-1548. PubMed ID: 30506571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasing de novo synthesis of long-chain ceramides.
    Cinar R; Godlewski G; Liu J; Tam J; Jourdan T; Mukhopadhyay B; Harvey-White J; Kunos G
    Hepatology; 2014 Jan; 59(1):143-53. PubMed ID: 23832510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of diet-induced hepatic steatosis by peripheral CB1 receptor blockade in mice is p53/miRNA-22/SIRT1/PPARα dependent.
    Azar S; Udi S; Drori A; Hadar R; Nemirovski A; Vemuri KV; Miller M; Sherill-Rofe D; Arad Y; Gur-Wahnon D; Li X; Makriyannis A; Ben-Zvi D; Tabach Y; Ben-Dov IZ; Tam J
    Mol Metab; 2020 Dec; 42():101087. PubMed ID: 32987186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of adiponectin in the metabolic effects of cannabinoid type 1 receptor blockade in mice with diet-induced obesity.
    Tam J; Godlewski G; Earley BJ; Zhou L; Jourdan T; Szanda G; Cinar R; Kunos G
    Am J Physiol Endocrinol Metab; 2014 Feb; 306(4):E457-68. PubMed ID: 24381003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic SIRT1 attenuates hepatic steatosis and controls energy balance in mice by inducing fibroblast growth factor 21.
    Li Y; Wong K; Giles A; Jiang J; Lee JW; Adams AC; Kharitonenkov A; Yang Q; Gao B; Guarente L; Zang M
    Gastroenterology; 2014 Feb; 146(2):539-49.e7. PubMed ID: 24184811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Celastrol ameliorates liver metabolic damage caused by a high-fat diet through Sirt1.
    Zhang Y; Geng C; Liu X; Li M; Gao M; Liu X; Fang F; Chang Y
    Mol Metab; 2017 Jan; 6(1):138-147. PubMed ID: 28123944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver.
    Jeong WI; Osei-Hyiaman D; Park O; Liu J; Bátkai S; Mukhopadhyay P; Horiguchi N; Harvey-White J; Marsicano G; Lutz B; Gao B; Kunos G
    Cell Metab; 2008 Mar; 7(3):227-35. PubMed ID: 18316028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of fatty acid oxidation resists weight gain, ameliorates hepatic steatosis and reduces cardiometabolic risk factors.
    Vijayakumar RS; Lin Y; Shia KS; Yeh YN; Hsieh WP; Hsiao WC; Chang CP; Chao YS; Hung MS
    Int J Obes (Lond); 2012 Jul; 36(7):999-1006. PubMed ID: 21894162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major urinary protein 1 interacts with cannabinoid receptor type 1 in fatty acid-induced hepatic insulin resistance in a mouse hepatocyte model.
    Chen CC; Lee TY; Kwok CF; Hsu YP; Shih KC; Lin YJ; Ho LT
    Biochem Biophys Res Commun; 2015 May; 460(4):1063-8. PubMed ID: 25843798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigallocatechin-3-Gallate-Rich Green Tea Extract Ameliorates Fatty Liver and Weight Gain in Mice Fed a High Fat Diet by Activating the Sirtuin 1 and AMP Activating Protein Kinase Pathway.
    Bae UJ; Park J; Park IW; Chae BM; Oh MR; Jung SJ; Ryu GS; Chae SW; Park BH
    Am J Chin Med; 2018; 46(3):617-632. PubMed ID: 29595075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoacylglycerol lipase deficiency affects diet-induced obesity, fat absorption, and feeding behavior in CB
    Yoshida K; Kita Y; Tokuoka SM; Hamano F; Yamazaki M; Sakimura K; Kano M; Shimizu T
    FASEB J; 2019 Feb; 33(2):2484-2497. PubMed ID: 30265576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gα12 ablation exacerbates liver steatosis and obesity by suppressing USP22/SIRT1-regulated mitochondrial respiration.
    Kim TH; Yang YM; Han CY; Koo JH; Oh H; Kim SS; You BH; Choi YH; Park TS; Lee CH; Kurose H; Noureddin M; Seki E; Wan YY; Choi CS; Kim SG
    J Clin Invest; 2018 Dec; 128(12):5587-5602. PubMed ID: 30300140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic Sirt1 deficiency in mice impairs mTorc2/Akt signaling and results in hyperglycemia, oxidative damage, and insulin resistance.
    Wang RH; Kim HS; Xiao C; Xu X; Gavrilova O; Deng CX
    J Clin Invest; 2011 Nov; 121(11):4477-90. PubMed ID: 21965330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LB100 ameliorates nonalcoholic fatty liver disease
    Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
    World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of Direct Effects of the CB1 Receptor Antagonist Rimonabant on Fatty Acid Oxidation and Glycogenolysis in Liver and Muscle Cells in vitro.
    Müller GA; Wied S; Herling AW
    Biochemistry (Mosc); 2019 Aug; 84(8):954-962. PubMed ID: 31522677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinoic acid ameliorates high-fat diet-induced liver steatosis through sirt1.
    Geng C; Xu H; Zhang Y; Gao Y; Li M; Liu X; Gao M; Wang X; Liu X; Fang F; Chang Y
    Sci China Life Sci; 2017 Nov; 60(11):1234-1241. PubMed ID: 28667519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity.
    Ravinet Trillou C; Delgorge C; Menet C; Arnone M; Soubrié P
    Int J Obes Relat Metab Disord; 2004 Apr; 28(4):640-8. PubMed ID: 14770190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic cannabinoid receptor-1 mediates diet-induced insulin resistance via inhibition of insulin signaling and clearance in mice.
    Liu J; Zhou L; Xiong K; Godlewski G; Mukhopadhyay B; Tam J; Yin S; Gao P; Shan X; Pickel J; Bataller R; O'Hare J; Scherer T; Buettner C; Kunos G
    Gastroenterology; 2012 May; 142(5):1218-1228.e1. PubMed ID: 22307032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rimonabant, a cannabinoid receptor type 1 inverse agonist, inhibits hepatocyte lipogenesis by activating liver kinase B1 and AMP-activated protein kinase axis downstream of Gα i/o inhibition.
    Wu HM; Yang YM; Kim SG
    Mol Pharmacol; 2011 Nov; 80(5):859-69. PubMed ID: 21803969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the cannabinoid CB1 antagonist rimonabant on hepatic mitochondrial function in rats fed a high-fat diet.
    Flamment M; Gueguen N; Wetterwald C; Simard G; Malthièry Y; Ducluzeau PH
    Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1162-70. PubMed ID: 19724020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.